Is Rocephin Safe During Pregnancy?
The U.S. Food and Drug Administration (FDA) considers
Rocephin® (
ceftriaxone) a pregnancy Category B medicine, which means that it has not been studied in pregnant women. However, when studied in pregnant animals, Rocephin showed no negative effects on unborn babies.
Rocephin and Pregnancy Category B
The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is assigned to medicines that do not cause side effects to the fetus in animal studies, but for which no human studies on pregnant women have been done.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child.
If you are pregnant and have been prescribed Rocephin, let your healthcare provider know. Your healthcare provider will consider both the benefits and risks of Rocephin during pregnancy before making a recommendation for your particular situation.